Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.
Saved in:
| Title: | Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array. |
|---|---|
| Authors: | Braunschweig T; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. till.braunschweig@web.de.; Institute of Pathology, RWTH Aachen University, Aachen, 52074, Germany. till.braunschweig@web.de., Chung JY; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. chungjo@mail.nih.gov., Choi CH; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. chelhun.choi@nih.gov.; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710, Republic of Korea. chelhun.choi@nih.gov., Cho H; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. hanbyoul@yuhs.ac.; Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 135-720, Republic of Korea. hanbyoul@yuhs.ac., Chen QR; Oncogenomics Section, Pediatric Oncology Branch, National Cancer Insititute, National Institutes of Health, Bethesda, MD, 20892, USA. chenqi@mail.nih.gov.; Present affiliation: Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. chenqi@mail.nih.gov., Xie R; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. xie_ran@yahoo.com., Perry C; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. perrycd@mail.nih.gov.; Antibody Characterization Laboratory, Advanced Technology Program, Leidos Biomedical Research, Inc., Frederick, MD, USA. perrycd@mail.nih.gov., Khan J; Oncogenomics Section, Pediatric Oncology Branch, National Cancer Insititute, National Institutes of Health, Bethesda, MD, 20892, USA. khanjav@mail.nih.gov., Hewitt SM; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. genejock@helix.nih.gov. |
| Source: | Diagnostic pathology [Diagn Pathol] 2015 May 29; Vol. 10, pp. 53. Date of Electronic Publication: 2015 May 29. |
| Publication Type: | Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-1596 (Electronic) Linking ISSN: 17461596 NLM ISO Abbreviation: Diagn Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26022333 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Braunschweig+T%22">Braunschweig T</searchLink>; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. till.braunschweig@web.de.; Institute of Pathology, RWTH Aachen University, Aachen, 52074, Germany. till.braunschweig@web.de.<br /><searchLink fieldCode="AU" term="%22Chung+JY%22">Chung JY</searchLink>; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. chungjo@mail.nih.gov.<br /><searchLink fieldCode="AU" term="%22Choi+CH%22">Choi CH</searchLink>; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. chelhun.choi@nih.gov.; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710, Republic of Korea. chelhun.choi@nih.gov.<br /><searchLink fieldCode="AU" term="%22Cho+H%22">Cho H</searchLink>; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. hanbyoul@yuhs.ac.; Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 135-720, Republic of Korea. hanbyoul@yuhs.ac.<br /><searchLink fieldCode="AU" term="%22Chen+QR%22">Chen QR</searchLink>; Oncogenomics Section, Pediatric Oncology Branch, National Cancer Insititute, National Institutes of Health, Bethesda, MD, 20892, USA. chenqi@mail.nih.gov.; Present affiliation: Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. chenqi@mail.nih.gov.<br /><searchLink fieldCode="AU" term="%22Xie+R%22">Xie R</searchLink>; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. xie&#95;ran@yahoo.com.<br /><searchLink fieldCode="AU" term="%22Perry+C%22">Perry C</searchLink>; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. perrycd@mail.nih.gov.; Antibody Characterization Laboratory, Advanced Technology Program, Leidos Biomedical Research, Inc., Frederick, MD, USA. perrycd@mail.nih.gov.<br /><searchLink fieldCode="AU" term="%22Khan+J%22">Khan J</searchLink>; Oncogenomics Section, Pediatric Oncology Branch, National Cancer Insititute, National Institutes of Health, Bethesda, MD, 20892, USA. khanjav@mail.nih.gov.<br /><searchLink fieldCode="AU" term="%22Hewitt+SM%22">Hewitt SM</searchLink>; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. genejock@helix.nih.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101251558%22">Diagnostic pathology</searchLink> [Diagn Pathol] 2015 May 29; Vol. 10, pp. 53. <i>Date of Electronic Publication: </i>2015 May 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Intramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101251558 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1746-1596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217461596%22">17461596 </searchLink><i>NLM ISO Abbreviation: </i>Diagn Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26022333 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13000-015-0290-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 53 Titles: – TitleFull: Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Braunschweig T – PersonEntity: Name: NameFull: Chung JY – PersonEntity: Name: NameFull: Choi CH – PersonEntity: Name: NameFull: Cho H – PersonEntity: Name: NameFull: Chen QR – PersonEntity: Name: NameFull: Xie R – PersonEntity: Name: NameFull: Perry C – PersonEntity: Name: NameFull: Khan J – PersonEntity: Name: NameFull: Hewitt SM IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 05 Text: 2015 May 29 Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1746-1596 Numbering: – Type: volume Value: 10 Titles: – TitleFull: Diagnostic pathology Type: main |
| ResultId | 1 |